None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: School-going children aged 10 to 16 years presenting with clinically diagnosed premature graying of hair (defined as the presence of five or more visibly non-pigmented scalp hairs), assessed using the Graying Severity Score (GSS), and whose parents or legal guardians provide written informed consent along with child assent, will be included in the study. Participants must be willing to comply with the study protocol and attend regular monthly follow-up visits for a duration of six months.
Exclusion criteria
Exclusion criteria: Children with inflammatory, infectious, or structural scalp disorders that may interfere with normal hair pigmentation; those diagnosed with systemic illnesses such as uncontrolled thyroid disorders, autoimmune diseases, or severe nutritional deficiencies requiring immediate medical intervention; children currently undergoing any active treatment specifically for premature graying of hair; those with known hypersensitivity to homoeopathic medicines; and participants who are unlikely to comply with the study protocol or regular follow-up visits will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of the study will be the change in the severity of premature graying of hair, as measured by the Graying Severity Score (GSS), from baseline to the end of six months of treatment. The outcome will be assessed through quantitative comparison of GSS scores between the two groups and within each group over time to determine the efficacy of individualized homoeopathic treatment, with or without dietary advice.Timepoint: Outcome measures will be assessed at predefined time intervals during the study period as follows: Baseline (Week 0) Prior to initiation of intervention Week 4 (1 Month) First follow-up assessment Week 8 (2 Months) Second follow-up assessment | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcomes will include improvement in associated symptoms such as hair fall, hair texture, & scalp health; patient & parent-reported satisfaction with treatment; & assessment of overall well-being during the six-month study period. Safety will also be evaluated by monitoring any adverse events throughout the study duration.Timepoint: Secondary Outcome Time Points of Assessment The secondary outcomes will be assessed at the following predefined time points: Baseline (Week 0) Prior to initiation of intervention Week 4 First follow-up assessment Week 8 Second follow-up assessment | — |
Countries
India
Contacts
Sonajirao Kshirsagar homoeopathic medical college, Beed